Importantly, the inhibition of GSK3β seems to reduce the survival and proliferation of tumor cells and to increase apoptosis by raising the levels of p53-dependent Bax and the cytoplasmatic release of cyt c, with the ensuing activation of caspase-9 and caspase-3 10. The gene discussed is TP53; the disease is neoplasm.